august 24 2025 glp-1 Pipeline Update: - Prime Therapeutics GLP-1 Receptor Agonists in Hidradenitis
Description
Our clinicians break down what matters.
We present the case of a 32-year-old woman with no prior medical history who developed hematochezia and abdominal pain after six weeks of tirzepatide therapy for weight loss
newsletter, UnitedHealths financial miscues, an $800 million revenue cycle bonanza, and much more.
Understanding tolerance mechanisms and personalized dose optimization helps many patients restart momentum without switching medications
A new real-world study in JAMA Network Open looked at 126,984 adults with overweight or obesity, without diabetes, who started a GLP-1RA between 2019 and 2024
